PTC Therapeutics PTCT Free cash flow yield
Free cash flow yield at other companies
Other financials
Where this comes from
Calculated from PTC Therapeutics’s reported figures.
Based on trailing twelve months.
The official record: PTC Therapeutics’s 10-Q, filed May 6, 2025, on SEC EDGAR. View the filing →
Ask your AI about PTC Therapeutics's free cash flow yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is PTC Therapeutics's free cash flow yield?
- PTC Therapeutics (PTCT) reported free cash flow yield of 17.2% in Q1 2025.
- How has PTC Therapeutics's free cash flow yield changed year-over-year?
- PTC Therapeutics's free cash flow yield increased by 540.8% year-over-year, from -3.9% to 17.2%.
- What is the long-term trend for PTC Therapeutics's free cash flow yield?
- Over 3 years (2021 to 2024), PTC Therapeutics's free cash flow yield has grown at a -30.9% compound annual growth rate (CAGR), from -9.9% to -3.3%.
- What does free cash flow yield mean?
- Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.